Mariann Polgar-Turcsanyi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Mariann Polgar-Turcsanyi

Showing results (1-10 of 29) with videos related to

Pageof 3

Sort By:

Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 25, 2025

Multiple sclerosis relapse risk factors across treatment erasEvan Madill, Brian Healy, Mariann Polgar-Turcsanyi, et al.

Medrxiv : the Preprint Server for Health Sciences|August 12, 2025

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple SclerosisJessica Jane Ye, Negar Molazedeh, Mariann Polgar-Turcsanyi, et al.

Archives of Neurology|January 14, 2009

Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosisMark P Gorman, Brian C Healy, Mariann Polgar-Turcsanyi, et al.

Journal of the Neurological Sciences|February 5, 2026

Correlation between blood biomarkers and patient-reported outcomes (PROs) of depression and mental health scores in individuals with multiple sclerosis (iwMS)Moogeh Baharnoori, Bonnie Glanz, Mariann Polgar-Turcsanyi, et al.

Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 31, 2005

Multiple sclerosis medical image analysis and information managementLifeng Liu, Dominik Meier, Mariann Polgar-Turcsanyi, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2025

Change in serum neurofilament light chain and glial fibrillary acidic protein levels with high-efficacy and low-efficacy early therapy in multiple sclerosisEvan Madill, Vanessa Moreira Ferreira, Brian Healy, et al.

Annals of Clinical and Translational Neurology|September 6, 2024

Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosisEvan Madill, Brian C Healy, Negar Molazadeh, et al.

Multiple Sclerosis and Related Disorders|May 25, 2024

Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapiesSarah Conway, Saumya Gupta, Brian Healy, et al.

Journal of Neuroinflammation|June 1, 2023

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort studyAlicia Gonzalez-Martinez, Gauruv Bose, Hrishikesh Lokhande, et al.

Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 9, 2021

Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disabilityMarinos G Sotiropoulos, Hrishikesh Lokhande, Brian C Healy, et al.

Pageof 3

Search research articles

Showing results (1-10 of 29) with videos related to

Sort By:

Pageof 3

Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 25, 2025

Multiple sclerosis relapse risk factors across treatment erasEvan Madill, Brian Healy, Mariann Polgar-Turcsanyi, et al.

Medrxiv : the Preprint Server for Health Sciences|August 12, 2025

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple SclerosisJessica Jane Ye, Negar Molazedeh, Mariann Polgar-Turcsanyi, et al.

Archives of Neurology|January 14, 2009

Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosisMark P Gorman, Brian C Healy, Mariann Polgar-Turcsanyi, et al.

Journal of the Neurological Sciences|February 5, 2026

Correlation between blood biomarkers and patient-reported outcomes (PROs) of depression and mental health scores in individuals with multiple sclerosis (iwMS)Moogeh Baharnoori, Bonnie Glanz, Mariann Polgar-Turcsanyi, et al.

Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 31, 2005

Multiple sclerosis medical image analysis and information managementLifeng Liu, Dominik Meier, Mariann Polgar-Turcsanyi, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2025

Change in serum neurofilament light chain and glial fibrillary acidic protein levels with high-efficacy and low-efficacy early therapy in multiple sclerosisEvan Madill, Vanessa Moreira Ferreira, Brian Healy, et al.

Annals of Clinical and Translational Neurology|September 6, 2024

Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosisEvan Madill, Brian C Healy, Negar Molazadeh, et al.

Multiple Sclerosis and Related Disorders|May 25, 2024

Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapiesSarah Conway, Saumya Gupta, Brian Healy, et al.

Journal of Neuroinflammation|June 1, 2023

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort studyAlicia Gonzalez-Martinez, Gauruv Bose, Hrishikesh Lokhande, et al.

Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 9, 2021

Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disabilityMarinos G Sotiropoulos, Hrishikesh Lokhande, Brian C Healy, et al.

Pageof 3